Funder
U.S. Department of Veterans Affairs
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference18 articles.
1. •• Anker SD, Butler J, Filippatos G et al. Empagliflozin in heart failure with a preservedejection fraction. N Engl J Med 2021; 385(16):1451–1461. (In a randomized trial of 5988 heart failure patients with left ventricular ejection fraction >40%, empagliflozin (compared with placebo) was associated with a significant risk reduction in the composite endpoint of cardiovascular death and first hospitalization for heart failure.)
2. Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of cardiovascular disease studies presented at the 2021 European Society of Cardiology Congress. Curr Atheroscler Rep. 2021;23(12):76.
3. Hussain A, Al Rifai M, Mahtta D, Liu J, Jain V, Virani SS. Highlights from studies presented at the American Heart Association Scientific Sessions 2020: navigating new roads in prevention. Curr Atheroscler Rep. 2021;23(1):4.
4. Jain V, Al Rifai M, Mahtta D, Liu J, Hussain A, Virani SS. Highlights from studies presented at the virtual American College of Cardiology Scientific Sessions 2021: Staying updated with the latest advancements in prevention. Curr Atheroscler Rep. 2021;23(9):50.
5. Jia X, Lee MT, Ramsey DJ et al. Facility-level variation in reported statin-associated side effects among patients with atherosclerotic cardiovascular disease-perspective from the Veterans Affair healthcare system. Cardiovasc Drugs Ther 2021; Online ahead of print.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献